Achmea Investment Management B.V. Boosts Stock Position in DaVita Inc. (NYSE:DVA)

Achmea Investment Management B.V. increased its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 71.0% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 25,793 shares of the company's stock after acquiring an additional 10,710 shares during the quarter. Achmea Investment Management B.V.'s holdings in DaVita were worth $3,946,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of DVA. UMB Bank n.a. boosted its stake in shares of DaVita by 65.5% in the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock valued at $29,000 after purchasing an additional 76 shares during the last quarter. Copia Wealth Management bought a new stake in shares of DaVita in the 4th quarter valued at $30,000. SBI Securities Co. Ltd. bought a new stake in shares of DaVita in the 4th quarter valued at $41,000. Coppell Advisory Solutions LLC boosted its stake in shares of DaVita by 50.0% in the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock valued at $45,000 after purchasing an additional 100 shares during the last quarter. Finally, Canada Post Corp Registered Pension Plan bought a new stake in shares of DaVita in the 4th quarter valued at $55,000. 90.12% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently issued reports on DVA shares. Wall Street Zen upgraded shares of DaVita from a "hold" rating to a "buy" rating in a research report on Friday, April 25th. Truist Financial lowered their price objective on shares of DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a report on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, DaVita has an average rating of "Hold" and an average price target of $164.50.

DaVita Price Performance

Shares of DVA stock traded up $0.61 during trading hours on Friday, hitting $141.70. 1,154,954 shares of the company's stock were exchanged, compared to its average volume of 805,523. The company has a current ratio of 1.25, a quick ratio of 1.20 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 12-month low of $131.76 and a 12-month high of $179.60. The company has a market capitalization of $10.70 billion, a PE ratio of 14.04, a PEG ratio of 0.98 and a beta of 1.11. The business's 50 day simple moving average is $139.46 and its 200-day simple moving average is $149.49.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.75 by $0.25. DaVita had a net margin of 6.63% and a return on equity of 176.11%. The business had revenue of $3.22 billion for the quarter, compared to analysts' expectations of $3.22 billion. During the same quarter in the previous year, the business posted $2.26 earnings per share. The firm's revenue for the quarter was up 5.0% compared to the same quarter last year. On average, equities research analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.